Disease | cystic fibrosis |
Symptom | C0876973|pulmonary infection |
Sentences | 12 |
PubMedID- 21991261 | For example, p. aeruginosa isolates obtained from chronic pulmonary infections of patients with cystic fibrosis (cf) are often mucoid. |
PubMedID- 23152277 | However, there is considerable evidence to suggest that pseudomonas aeruginosa actually grows in a biofilm (or slime layer) in the airways of cystic fibrosis patients with chronic pulmonary infections. |
PubMedID- 25118167 | Methicillin-resistant staphylococcus aureus (mrsa) causes chronic pulmonary infections in patients with cystic fibrosis (cf). |
PubMedID- 24031589 | Pseudomonas aeruginosa is a common cause of chronic pulmonary infection in patients with cystic fibrosis (cf). |
PubMedID- 24489509 | Treatment of pseudomonas and staphylococcus bronchopulmonary infection in patients with cystic fibrosis. |
PubMedID- 22558432 | Background: given the polymicrobial nature of pulmonary infections in patients with cystic fibrosis (cf), it is essential to enhance our knowledge on the composition of the microbial community to improve patient management. |
PubMedID- 21395432 | Abstract at present, the only approved inhaled antipseudomonal antibiotics for chronic pulmonary infections in patients with cystic fibrosis (cf) are nebulized solutions. |
PubMedID- 23030647 | During the last decades it has emerged as a cause of chronic pulmonary infection in patients with cystic fibrosis (cf). |
PubMedID- 21747788 | A number of aminoglycosides are commonly used in the treatment of p. aeruginosa infections (e.g., tobramycin, gentamicin, amikacin; gilbert et al., 2003; bartlett, 2004), particularly pulmonary infections in patients with cystic fibrosis (cf) where amikacin and, in particular, tobramycin are routinely employed (canton et al., 2005; taccetti et al., 2008). |
PubMedID- 22683550 | P. aeruginosa is also responsible for pulmonary infection of patients with cystic fibrosis . |
PubMedID- 21750293 | Context: early pulmonary infection in children with cystic fibrosis leads to increased morbidity and mortality. |
PubMedID- 22551926 | Burkholderia cepacia complex (bcc) is a group of 17 closely related bacterial species that can cause pulmonary infection in patients with cystic fibrosis (cf). |
Page: 1